$PRPO
Precipio, Inc.

2013 Q3 Form 10-Q Financial Statement

#000104396113000008 Filed on August 08, 2013

View on sec.gov

Income Statement

Concept 2013 Q3 2013 Q2 2012 Q2
Revenue $6.646M $7.306M $9.093M
YoY Change -15.76% -19.65% 18.6%
Cost Of Revenue $4.196M $4.333M $4.531M
YoY Change 2.62% -4.37% 45.6%
Gross Profit $2.450M $2.973M $4.562M
YoY Change -35.53% -34.83% 0.15%
Gross Profit Margin 36.86% 40.69% 50.17%
Selling, General & Admin $7.226M $4.982M $5.278M
YoY Change 29.99% -5.61% -5.56%
% of Gross Profit 294.94% 167.57% 115.69%
Research & Development $630.0K $913.0K $654.0K
YoY Change -5.69% 39.6% 12.95%
% of Gross Profit 25.71% 30.71% 14.34%
Depreciation & Amortization $671.0K $687.0K $532.0K
YoY Change 35.56% 29.14% 6.61%
% of Gross Profit 27.39% 23.11% 11.66%
Operating Expenses $7.856M $5.895M $5.932M
YoY Change 26.16% -0.62% -4.0%
Operating Profit -$5.406M -$2.922M -$1.370M
YoY Change 122.74% 113.28% -15.64%
Interest Expense -$160.0K $50.00K $770.0K
YoY Change -23.81% -93.51% -420.83%
% of Operating Profit
Other Income/Expense, Net $1.000K $0.00 $8.000K
YoY Change -116.67% -100.0% 700.0%
Pretax Income -$5.560M -$2.873M -$593.0K
YoY Change 110.61% 384.49% -90.28%
Income Tax -$8.000K -$6.000K -$30.00K
% Of Pretax Income
Net Earnings -$5.552M -$2.867M -$563.0K
YoY Change 101.6% 409.24% -90.61%
Net Earnings / Revenue -83.54% -39.24% -6.19%
Basic Earnings Per Share
Diluted Earnings Per Share -$277.5M -$143.5M -$56.00M
COMMON SHARES
Basic Shares Outstanding 88.25M shares 88.25M shares 71.65M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q3 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.020M $6.390M $6.300M
YoY Change -54.06% 1.43% 138.64%
Cash & Equivalents $4.016M $6.388M $6.297M
Short-Term Investments
Other Short-Term Assets $1.290M $1.083M $889.0K
YoY Change 8.77% 21.82% 3.37%
Inventory $4.454M $4.407M $4.031M
Prepaid Expenses
Receivables $4.414M $8.039M $8.621M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $14.17M $19.92M $28.83M
YoY Change -36.99% -30.92% 105.91%
LONG-TERM ASSETS
Property, Plant & Equipment $2.120M $2.151M $1.842M
YoY Change 1.39% 16.78% 4.01%
Goodwill $6.918M $6.918M $6.440M
YoY Change 3.66% 7.42% 2.63%
Intangibles $9.563M $9.941M $7.397M
YoY Change -16.73% 34.39% -13.2%
Long-Term Investments
YoY Change
Other Assets $405.0K $436.0K $161.0K
YoY Change 183.22% 170.81% 23.85%
Total Long-Term Assets $19.01M $19.45M $15.84M
YoY Change -6.8% 22.77% -5.14%
TOTAL ASSETS
Total Short-Term Assets $14.17M $19.92M $28.83M
Total Long-Term Assets $19.01M $19.45M $15.84M
Total Assets $33.18M $39.36M $44.67M
YoY Change -22.63% -11.88% 45.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.907M $1.748M $1.477M
YoY Change 25.71% 18.35% 5.5%
Accrued Expenses $2.393M $2.286M $3.884M
YoY Change -34.02% -41.14% 5.51%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $1.091M $727.0K $6.061M
YoY Change -84.32% -88.01% 2655.0%
Total Short-Term Liabilities $8.991M $7.914M $14.77M
YoY Change -45.84% -46.42% 49.12%
LONG-TERM LIABILITIES
Long-Term Debt $5.469M $7.273M $1.345M
YoY Change 1120.76% 440.74% -81.84%
Other Long-Term Liabilities $1.221M $1.235M $1.134M
YoY Change 4.99% 8.91% 12.5%
Total Long-Term Liabilities $6.690M $8.508M $2.479M
YoY Change 315.27% 243.2% -70.54%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.991M $7.914M $14.77M
Total Long-Term Liabilities $6.690M $8.508M $2.479M
Total Liabilities $17.79M $18.35M $19.35M
YoY Change -12.43% -5.19% -33.09%
SHAREHOLDERS EQUITY
Retained Earnings -$164.3M -$158.6M -$146.4M
YoY Change 10.06% 8.34% 2.64%
Common Stock $882.0K $887.0K $721.0K
YoY Change 22.33% 23.02% 44.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $15.39M $21.02M $25.32M
YoY Change
Total Liabilities & Shareholders Equity $33.18M $39.36M $44.67M
YoY Change -22.63% -11.88% 45.51%

Cashflow Statement

Concept 2013 Q3 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income -$5.552M -$2.867M -$563.0K
YoY Change 101.6% 409.24% -90.61%
Depreciation, Depletion And Amortization $671.0K $687.0K $532.0K
YoY Change 35.56% 29.14% 6.61%
Cash From Operating Activities -$640.0K -$2.360M -$2.440M
YoY Change -75.19% -3.28% -6200.0%
INVESTING ACTIVITIES
Capital Expenditures -$160.0K -$260.0K -$160.0K
YoY Change -95.65% 62.5% 23.08%
Acquisitions
YoY Change
Other Investing Activities -$80.00K -$30.00K -$9.050M
YoY Change -101.67% -99.67% 6364.29%
Cash From Investing Activities -$240.0K -$300.0K -$9.200M
YoY Change -122.02% -96.74% 3307.41%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.540M 1.320M -1.330M
YoY Change 1440.0% -199.25% 303.03%
NET CHANGE
Cash From Operating Activities -640.0K -2.360M -2.440M
Cash From Investing Activities -240.0K -300.0K -9.200M
Cash From Financing Activities -1.540M 1.320M -1.330M
Net Change In Cash -2.420M -1.340M -12.97M
YoY Change 52.2% -89.67% 2216.07%
FREE CASH FLOW
Cash From Operating Activities -$640.0K -$2.360M -$2.440M
Capital Expenditures -$160.0K -$260.0K -$160.0K
Free Cash Flow -$480.0K -$2.100M -$2.280M
YoY Change -143.64% -7.89% -1441.18%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1748000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2052000 USD
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8039000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8081000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3686000 USD
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2286000 USD
CY2013Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12703000 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12340000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
262000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
435000 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
170881000 USD
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
178448000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
162000 USD
CY2011Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1088000 USD
CY2013Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2549000 USD
CY2013Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2362000 USD
CY2012Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1236000 USD
CY2012Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1079000 USD
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2171000 USD
CY2012Q2 us-gaap Allowance For Doubtful Accounts Receivable Charge Offs
AllowanceForDoubtfulAccountsReceivableChargeOffs
339000 USD
us-gaap Allowance For Doubtful Accounts Receivable Charge Offs
AllowanceForDoubtfulAccountsReceivableChargeOffs
822000 USD
CY2013Q2 us-gaap Allowance For Doubtful Accounts Receivable Charge Offs
AllowanceForDoubtfulAccountsReceivableChargeOffs
795000 USD
us-gaap Allowance For Doubtful Accounts Receivable Charge Offs
AllowanceForDoubtfulAccountsReceivableChargeOffs
2006000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
600000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
900000 USD
CY2012Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000 USD
CY2013Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
29416204 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
40008668 shares
CY2013Q2 us-gaap Assets
Assets
39363000 USD
CY2012Q4 us-gaap Assets
Assets
38791000 USD
CY2012Q2 us-gaap Assets
Assets
44672000 USD
CY2013Q2 us-gaap Assets Current
AssetsCurrent
19917000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
18717000 USD
us-gaap Capital Leases Income Statement Amortization Expense
CapitalLeasesIncomeStatementAmortizationExpense
100000 USD
CY2013Q2 us-gaap Capital Leases Income Statement Amortization Expense
CapitalLeasesIncomeStatementAmortizationExpense
100000 USD
us-gaap Capital Leases Income Statement Amortization Expense
CapitalLeasesIncomeStatementAmortizationExpense
100000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6388000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4497000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6297000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4946000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1891000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1351000 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0085
CY2013Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
26643676 shares
CY2013Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
8300000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
88245725 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71645725 shares
CY2012Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19000000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71645725 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
88245725 shares
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
887000 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
721000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6627000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-614000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2867000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3249000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7589000 USD
CY2013Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3896000 USD
CY2012Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4531000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8633000 USD
CY2013Q2 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
8000000 USD
CY2012Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
6171000 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
3000000 USD
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
0 USD
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
25000 USD
CY2013Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1089000 USD
CY2012Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
532000 USD
CY2013Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
687000 USD
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1171000 USD
us-gaap Depreciation
Depreciation
300000 USD
CY2012Q2 us-gaap Depreciation
Depreciation
200000 USD
us-gaap Depreciation
Depreciation
300000 USD
CY2013Q2 us-gaap Depreciation
Depreciation
200000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1431000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1045000 USD
CY2012Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
1260000 USD
CY2013Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
1623000 USD
us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
362000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-46000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.001
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1121000 USD
CY2013Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
997000 USD
CY2012Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
600000 USD
CY2013Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
700000 USD
us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P3Y6M
us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.55
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases Sales Issuances Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements
0 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases Sales Issuances Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements
3100000 USD
CY2013Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
300000 USD
CY2012Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
2100000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2805000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3698000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1700000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1700000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1700000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1700000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
13569000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
13639000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
9941000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10764000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
62000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-9000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 USD
CY2013Q2 us-gaap Goodwill
Goodwill
6918000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
6918000 USD
CY2012Q2 us-gaap Gross Profit
GrossProfit
4562000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
3410000 USD
us-gaap Gross Profit
GrossProfit
7091000 USD
us-gaap Gross Profit
GrossProfit
7666000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2873000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-593000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3285000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6394000 USD
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-30000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-26000 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
60000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-287000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1137000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2225000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2001000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
312000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-565000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-11000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-576000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
245000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-341000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
198000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
76000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
67000 USD
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10764000 USD
CY2013Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9941000 USD
us-gaap Interest Paid
InterestPaid
732000 USD
us-gaap Interest Paid
InterestPaid
460000 USD
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4057000 USD
CY2013Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3187000 USD
CY2012Q4 us-gaap Inventory Gross
InventoryGross
5708000 USD
CY2013Q2 us-gaap Inventory Gross
InventoryGross
5000000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
5092000 USD
CY2013Q2 us-gaap Inventory Net
InventoryNet
4407000 USD
CY2012Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
559000 USD
CY2012Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
509000 USD
CY2012Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
616000 USD
CY2013Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
611000 USD
CY2013Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
593000 USD
CY2011Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
511000 USD
CY2012Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
1547000 USD
CY2013Q2 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
1561000 USD
us-gaap Inventory Write Down
InventoryWriteDown
53000 USD
us-gaap Inventory Write Down
InventoryWriteDown
0 USD
CY2012Q2 us-gaap Inventory Write Down
InventoryWriteDown
52000 USD
CY2013Q2 us-gaap Inventory Write Down
InventoryWriteDown
0 USD
CY2013Q2 us-gaap Liabilities
Liabilities
18345000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
18517000 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
39363000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
38791000 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
7914000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
15268000 USD
CY2013Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
727000 USD
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
6171000 USD
CY2013Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
7273000 USD
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 USD
CY2012Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
10682000 USD
CY2013Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
10993000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16023000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8985000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9474000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1361000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5687000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5197000 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-563000 USD
us-gaap Net Income Loss
NetIncomeLoss
-3259000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6454000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-2867000 USD
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3048000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6816000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3589000 USD
CY2012Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-728000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
12000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
0 USD
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
5932000 USD
us-gaap Operating Expenses
OperatingExpenses
11475000 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
6332000 USD
us-gaap Operating Expenses
OperatingExpenses
13834000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2922000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1370000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-3809000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-6743000 USD
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
800000 USD
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
900000 USD
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1000000 USD
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1000000 USD
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
1300000 USD
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
500000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
500000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
600000 USD
CY2013Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1083000 USD
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1047000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
202000 USD
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
436000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
10000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-173000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-51000 USD
CY2012Q4 us-gaap Other Inventory Demo
OtherInventoryDemo
104000 USD
CY2013Q2 us-gaap Other Inventory Demo
OtherInventoryDemo
252000 USD
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1067000 USD
CY2013Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1067000 USD
CY2013Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1235000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1089000 USD
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
28000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
53000 USD
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
121000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
157000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
238000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
849000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
359000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
355000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
8994000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
CY2012Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
165000 USD
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
362000 USD
CY2013Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
181000 USD
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
330000 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
363000 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
330000 USD
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2586205 shares
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2586205 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2586205 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2586205 shares
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
26000 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
26000 USD
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reclassifications.</font></div><div style="line-height:120%;padding-top:18px;text-align:justify;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior year amounts have been reclassified in order to conform to the current year presentation regarding segment reporting. In the second quarter of 2013, we modified the presentation of our accrued preferred stock dividend payable from current liabilities to long term liabilities. As a result, we have revised the balance sheet presentation as of December 31, 2012. This revision from current liabilities to long term liabilities has no effect on total assets, liabilities or equity. </font></div><div style="line-height:120%;padding-top:18px;text-align:justify;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior year amounts have been reclassified in order to conform to the current year presentation regarding segment reporting.</font></div></div>
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
17483000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7570000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
8000000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
CY2013Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14854000 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14530000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2190000 USD
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2151000 USD
CY2012Q1 tbio Class Of Warrant Or Right Exercise Term
ClassOfWarrantOrRightExerciseTerm
P5Y
CY2013Q1 tbio Class Of Warrant Or Right Number Of Issued Warrants Or Rights
ClassOfWarrantOrRightNumberOfIssuedWarrantsOrRights
8300000 shares
CY2012Q1 tbio Class Of Warrant Or Right Number Of Issued Warrants Or Rights
ClassOfWarrantOrRightNumberOfIssuedWarrantsOrRights
13171268 shares
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
970000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2197000 USD
CY2013Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
608000 USD
CY2012Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
496000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
143000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
176000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
6171000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1317000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1202000 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
913000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1677000 USD
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
654000 USD
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-158605000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-151789000 USD
CY2012Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.00
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
7306000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
16299000 USD
CY2012Q2 us-gaap Sales Revenue Net
SalesRevenueNet
9093000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
14680000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10273000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12157000 USD
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5278000 USD
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5419000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
471000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
162000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P3Y
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.06
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.1135
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.008
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0103
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3020172 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.02
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
188333 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
486667 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1605000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
49000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
149000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1912500 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4353167 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5590667 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.05
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.80
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.00
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
1.66
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.06
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.39
CY2013Q1 us-gaap Share Price
SharePrice
0.50
CY2013Q2 us-gaap Share Price
SharePrice
0.40
CY2012Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P8Y2M8D
CY2013Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y6M18D
CY2013Q2 us-gaap Significant Purchase Commitment Remaining Minimum Amount Committed
SignificantPurchaseCommitmentRemainingMinimumAmountCommitted
2100000 USD
CY2013Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
16600000 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7571000 USD
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
21018000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
20274000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting period. In addition, estimates and assumptions associated with the determination of the fair value of certain assets and related impairments require considerable judgment by management. Actual results could differ from the estimates and assumptions used in preparing these consolidated financial statements.</font></div></div>
CY2012Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
900000 USD
CY2013Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
300000 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
67164626 shares
CY2012Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
71645725 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
86136333 shares
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
88245725 shares
CY2013Q2 tbio Accounts Receivable General Payment Terms
AccountsReceivableGeneralPaymentTerms
P30D
CY2013Q2 tbio Accounts Receivable International Extended Payment Terms Greater Than
AccountsReceivableInternationalExtendedPaymentTermsGreaterThan
P90D
tbio Adjustment Of Warrants Granted
AdjustmentOfWarrantsGranted
-600000 USD
tbio Adjustment Of Warrants Granted
AdjustmentOfWarrantsGranted
-1000000 USD
CY2013Q2 tbio Class Of Warrant Or Right Number Of Issued Warrants Or Rights
ClassOfWarrantOrRightNumberOfIssuedWarrantsOrRights
8300000 shares
CY2013Q1 tbio Class Of Warrant Or Right Number Of Issued Warrants Or Rights
ClassOfWarrantOrRightNumberOfIssuedWarrantsOrRights
1791268 shares
CY2013Q1 tbio Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Price Per Share
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsPricePerShare
0.75
CY2012Q1 tbio Convertible Notes Number Of Securities Called By Note
ConvertibleNotesNumberOfSecuritiesCalledByNote
3000000 shares
tbio Fair Value Assumptions Percentage Of Simulated Equity Values Below Down Round Financing Cut Off Point
FairValueAssumptionsPercentageOfSimulatedEquityValuesBelowDownRoundFinancingCutOffPoint
0.25
CY2013Q2 tbio Finite Lived Intangible Assets Amortization Expense Current Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseCurrentFiscalYear
1700000 USD
CY2012Q4 tbio Furniture Fixtures And Leasehold Impovements Gross
FurnitureFixturesAndLeaseholdImpovementsGross
3848000 USD
CY2013Q2 tbio Furniture Fixtures And Leasehold Impovements Gross
FurnitureFixturesAndLeaseholdImpovementsGross
3861000 USD
tbio Interest Income And Expense Net
InterestIncomeAndExpenseNet
-504000 USD
CY2012Q2 tbio Interest Income And Expense Net
InterestIncomeAndExpenseNet
-231000 USD
tbio Interest Income And Expense Net
InterestIncomeAndExpenseNet
-304000 USD
CY2013Q2 tbio Interest Income And Expense Net
InterestIncomeAndExpenseNet
-151000 USD
tbio Inventory Provision Write Offs
InventoryProvisionWriteOffs
5000 USD
CY2012Q2 tbio Inventory Provision Write Offs
InventoryProvisionWriteOffs
2000 USD
CY2013Q2 tbio Inventory Provision Write Offs
InventoryProvisionWriteOffs
18000 USD
tbio Inventory Provision Write Offs
InventoryProvisionWriteOffs
23000 USD
tbio Issuance Of Warrants Expected Exercise Period
IssuanceOfWarrantsExpectedExercisePeriod
P3Y7M10D
CY2013Q2 tbio Other Income Expense
OtherIncomeExpense
49000 USD
CY2012Q2 tbio Other Income Expense
OtherIncomeExpense
777000 USD
tbio Other Income Expense
OtherIncomeExpense
524000 USD
tbio Other Income Expense
OtherIncomeExpense
349000 USD
tbio Payments Of Stock Issuance Costs Reduction To Equity
PaymentsOfStockIssuanceCostsReductionToEquity
1500000 USD
CY2012Q1 tbio Proceeds From Issuance Of Common Stock And Convertable Notes
ProceedsFromIssuanceOfCommonStockAndConvertableNotes
22000000 USD
CY2011Q4 tbio Proceeds From Issuance Of Common Stock And Convertable Notes
ProceedsFromIssuanceOfCommonStockAndConvertableNotes
3000000 USD
tbio Share Based Compensation Arrangement By Share Based Payment Award Expiration Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod
P10Y
CY2013Q2 tbio Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.1487
CY2012Q2 tbio Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.0163
CY2012Q2 tbio Stock Warrants Expense
StockWarrantsExpense
-1000000 USD
tbio Stock Warrants Expense
StockWarrantsExpense
-1000000 USD
CY2013Q2 tbio Stock Warrants Expense
StockWarrantsExpense
-200000 USD
tbio Stock Warrants Expense
StockWarrantsExpense
-600000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001043961
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
88245725 shares
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
TRANSGENOMIC INC

Files In Submission

Name View Source Status
0001043961-13-000008-index-headers.html Edgar Link pending
0001043961-13-000008-index.html Edgar Link pending
0001043961-13-000008.txt Edgar Link pending
0001043961-13-000008-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R38.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R39.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R40.xml Edgar Link unprocessable
R41.htm Edgar Link pending
R41.xml Edgar Link unprocessable
R42.htm Edgar Link pending
R42.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending
tbio-20130630.xml Edgar Link completed
tbio-20130630.xsd Edgar Link pending
tbio-20130630_cal.xml Edgar Link unprocessable
tbio-20130630_def.xml Edgar Link unprocessable
tbio-20130630_lab.xml Edgar Link unprocessable
tbio-20130630_pre.xml Edgar Link unprocessable
tbio-2013630x10q.htm Edgar Link pending
tbio-ex311_2013630x10q.htm Edgar Link pending
tbio-ex312_20136x30x10q.htm Edgar Link pending
tbio-ex321_2013630x10q.htm Edgar Link pending
tbio-ex322_2013630x10q.htm Edgar Link pending